-
公开(公告)号:US20210246468A1
公开(公告)日:2021-08-12
申请号:US16973630
申请日:2019-06-11
摘要: The present invention relates to isolated polynucleotide and polypeptide sequences derived from novel chimpanzee adenovirus ChAd157, as well as to recombinant polynucleotides, vectors, adenoviruses, cells and compositions comprising said polynucleotide and polypeptide sequences.
-
公开(公告)号:US20210198321A1
公开(公告)日:2021-07-01
申请号:US16770963
申请日:2018-12-14
发明人: Stefania CAPONE , Antonella FOLGORI , Armin LAHM , Benjamin WIZEL
IPC分类号: C07K14/005 , C12N7/00 , A61K39/245
摘要: The invention provides Epstein-Barr Virus antigen polynucleotides, polypeptides and vectors; as well as immunogenic compositions comprising the same. It includes the use of Epstein-Barr Virus antigen constructs to produce vaccines for treating and preventing Epstein-Barr Virus infections and Epstein-Barr Virus-associated diseases, such as multiple sclerosis, rheumatoid arthritis and systemic lupus erythematosus.
-
公开(公告)号:US20240076318A1
公开(公告)日:2024-03-07
申请号:US18358350
申请日:2023-07-25
发明人: Stefania CAPONE , Antonella FOLGORI , Armin LAHM , Benjamin WIZEL
IPC分类号: C07K14/005 , A61K39/245 , C12N7/00
CPC分类号: C07K14/005 , A61K39/245 , C12N7/00 , A61K2039/70
摘要: The invention provides Epstein-Barr Virus antigen polynucleotides, polypeptides and vectors; as well as immunogenic compositions comprising the same. It includes the use of Epstein-Barr Virus antigen constructs to produce vaccines for treating and preventing Epstein-Barr Virus infections and Epstein-Barr Virus-associated diseases, such as multiple sclerosis, rheumatoid arthritis and systemic lupus erythematosus.
-
公开(公告)号:US20220275397A1
公开(公告)日:2022-09-01
申请号:US17742221
申请日:2022-05-11
摘要: The present invention relates to isolated polynucleotide and polypeptide sequences derived from novel chimpanzee adenovirus ChAd157, as well as to recombinant polynucleotides, vectors, adenoviruses, cells and compositions comprising said polynucleotide and polypeptide sequences.
-
公开(公告)号:US20220062409A1
公开(公告)日:2022-03-03
申请号:US17413203
申请日:2019-12-13
IPC分类号: A61K39/245 , A61K39/21 , A61K39/205 , A61P31/14 , A61P31/18 , A61P31/22
摘要: Simian adenoviral vectors and RNA molecules, each encoding an immunogen of interest, can be sequentially administered to provide potent and long-lasting immunity.
-
-
-
-